View in EDS HTML Full Text PDF Full Text

Antidepressants: general practitioners’ opinions and clinical practice.

Saved in:
Bibliographic Details
Title: Antidepressants: general practitioners’ opinions and clinical practice.
Authors: Rambelomanana, S. (AUTHOR), Depont, F. (AUTHOR), Forest, K. (AUTHOR), Hébert, G. (AUTHOR), Blazejewski, S. (AUTHOR), Fourrier‐Réglat, A. (AUTHOR), Molimard, M. (AUTHOR), Moore, N. (AUTHOR)
Source: Acta Psychiatrica Scandinavica. Jun2006, Vol. 113 Issue 6, p460-467. 8p. 3 Charts, 1 Graph.
Subjects: General practitioners, Antidepressants, Psychiatric drugs, Monoamine oxidase inhibitors, Neurotransmitter uptake inhibitors, Mental depression
Abstract: Objective: To describe and compare general practitioners’ (GPs) opinions on antidepressant drugs and their prescriptions to depressed patients. Method: Between November 2000 and July 2001 a representative sample of French GPs was asked their opinion of the 15 most prescribed antidepressants, and then to describe the treatments of the current depressive episode of four depressive patients each, their changes and the reasons thereof. Results: One hundred and eighty-one GPs and 778 patients participated. The best-ranked antidepressants by the GPs were paroxetine, fluoxetine, sertraline and clomipramine for efficacy, and paroxetine, tianeptine, sertraline and fluoxetine for tolerability. In patients, the drugs most often prescribed were fluoxetine, paroxetine, and sertraline. Those least often stopped for intolerance were moclobemide (0%), dosulepine (0%), venlafaxine (4.5%) and citalopram (5.0%), and maprotiline (0%), citalopram (1.7%) and venlafaxine (2.3%) for lack of efficacy. The best predictor for prescription of antidepressants was the GPs’ overall ranking, itself depending on opinions of the tolerability and efficacy of the drug. However, opinions of tolerability and efficacy were not related to the rates of treatment discontinuation for intolerability or inefficacy. Conclusion: Prescriber opinion does not seem related to actual product performance. [ABSTRACT FROM AUTHOR]
Copyright of Acta Psychiatrica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 20743605
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Antidepressants: general practitioners’ opinions and clinical practice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Rambelomanana%2C+S%2E%22">Rambelomanana, S.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Depont%2C+F%2E%22">Depont, F.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Forest%2C+K%2E%22">Forest, K.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hébert%2C+G%2E%22">Hébert, G.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Blazejewski%2C+S%2E%22">Blazejewski, S.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fourrier‐Réglat%2C+A%2E%22">Fourrier‐Réglat, A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Molimard%2C+M%2E%22">Molimard, M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moore%2C+N%2E%22">Moore, N.</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Acta+Psychiatrica+Scandinavica%22">Acta Psychiatrica Scandinavica</searchLink>. Jun2006, Vol. 113 Issue 6, p460-467. 8p. 3 Charts, 1 Graph.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22General+practitioners%22">General practitioners</searchLink><br /><searchLink fieldCode="DE" term="%22Antidepressants%22">Antidepressants</searchLink><br /><searchLink fieldCode="DE" term="%22Psychiatric+drugs%22">Psychiatric drugs</searchLink><br /><searchLink fieldCode="DE" term="%22Monoamine+oxidase+inhibitors%22">Monoamine oxidase inhibitors</searchLink><br /><searchLink fieldCode="DE" term="%22Neurotransmitter+uptake+inhibitors%22">Neurotransmitter uptake inhibitors</searchLink><br /><searchLink fieldCode="DE" term="%22Mental+depression%22">Mental depression</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Objective: To describe and compare general practitioners’ (GPs) opinions on antidepressant drugs and their prescriptions to depressed patients. Method: Between November 2000 and July 2001 a representative sample of French GPs was asked their opinion of the 15 most prescribed antidepressants, and then to describe the treatments of the current depressive episode of four depressive patients each, their changes and the reasons thereof. Results: One hundred and eighty-one GPs and 778 patients participated. The best-ranked antidepressants by the GPs were paroxetine, fluoxetine, sertraline and clomipramine for efficacy, and paroxetine, tianeptine, sertraline and fluoxetine for tolerability. In patients, the drugs most often prescribed were fluoxetine, paroxetine, and sertraline. Those least often stopped for intolerance were moclobemide (0%), dosulepine (0%), venlafaxine (4.5%) and citalopram (5.0%), and maprotiline (0%), citalopram (1.7%) and venlafaxine (2.3%) for lack of efficacy. The best predictor for prescription of antidepressants was the GPs’ overall ranking, itself depending on opinions of the tolerability and efficacy of the drug. However, opinions of tolerability and efficacy were not related to the rates of treatment discontinuation for intolerability or inefficacy. Conclusion: Prescriber opinion does not seem related to actual product performance. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Acta Psychiatrica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=20743605
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/j.1600-0447.2006.00793.x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 460
    Subjects:
      – SubjectFull: General practitioners
        Type: general
      – SubjectFull: Antidepressants
        Type: general
      – SubjectFull: Psychiatric drugs
        Type: general
      – SubjectFull: Monoamine oxidase inhibitors
        Type: general
      – SubjectFull: Neurotransmitter uptake inhibitors
        Type: general
      – SubjectFull: Mental depression
        Type: general
    Titles:
      – TitleFull: Antidepressants: general practitioners’ opinions and clinical practice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rambelomanana, S.
      – PersonEntity:
          Name:
            NameFull: Depont, F.
      – PersonEntity:
          Name:
            NameFull: Forest, K.
      – PersonEntity:
          Name:
            NameFull: Hébert, G.
      – PersonEntity:
          Name:
            NameFull: Blazejewski, S.
      – PersonEntity:
          Name:
            NameFull: Fourrier‐Réglat, A.
      – PersonEntity:
          Name:
            NameFull: Molimard, M.
      – PersonEntity:
          Name:
            NameFull: Moore, N.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: Jun2006
              Type: published
              Y: 2006
          Identifiers:
            – Type: issn-print
              Value: 0001690X
          Numbering:
            – Type: volume
              Value: 113
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Acta Psychiatrica Scandinavica
              Type: main
ResultId 1